XML 13 R39.htm IDEA: XBRL DOCUMENT v3.2.0.727
INTANGIBLE ASSETS (Details ) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2015
Dec. 31, 2014
Finite-Lived Intangible Assets    
Accumulated Amortization $ (127,244) $ (113,640)
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 1,421,020 1,342,228
Net Amount 1,293,776 1,228,588
Hormone therapy drug candidate patents - Pending [Member]    
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 678,213 675,982
Net Amount 678,213 675,982
Multiple trademarks for vitamins/supplements [Member]    
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 135,152 103,368
Net Amount 135,152 103,368
OPERA software patent [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 31,951 31,951
Accumulated Amortization (3,495) (2,496)
Net Amount $ 28,956 $ 29,455
Weighted Average Amortization Period 14 years 2 months 30 days 14 years 9 months
Development costs for corporate website [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 91,743 $ 91,743
Accumulated Amortization $ (91,743) $ (91,743)
Net Amount    
Approved Hormone Therapy Drug Candidate Patents [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 483,961 $ 439,184
Accumulated Amortization (32,006) (19,401)
Net Amount $ 451,955 $ 419,783
Weighted Average Amortization Period   18 years
Non-Amortizing Intangible Assets [Member]    
Finite-Lived Intangible Assets    
Weighted Average Amortization Period 17 years 6 months